July 16, 2024

The global small scale bioreactors market Growth Accelerated by Rising Demand from Pharmaceutical Industry

Small scale bioreactors are laboratory equipment used for cultivating biological cells or tissues needed for therapeutic or experimental purposes on a small scale in a controlled and standardized manner. They are used in vaccine manufacturing and stem cell therapy development. They allow scaling and optimization of production processes in a contained environment before transferring to large scale production.

The global small scale bioreactors market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Rising demand from pharmaceutical industry: The demand for small scale bioreactors is growing significantly from the pharmaceutical industry owing to their widespread application in drug discovery, biologics manufacturing and vaccine production. They allow quick screening of cell culture parameters and conditions for therapeutic antibody or vaccine candidates development. With biologics emerging as the major pharmaceutical product category, the use of small scale bioreactors is growing rapidly to facilitate drug development and production scale-up process before commercial manufacturing. This is a major trend driving the market growth over the forecast period.

Segment Analysis

The global Small Scale Bioreactors Market Demand is segmented based on type, control type, technology, end user and region. By type, stirred tank bioreactors dominate the segment owing to their high applications in research and development activities. They provide highly efficient mixing required for homogenous cell growth. By control type, manually operated bioreactors hold major share as they are affordable and easy to use in academic and research settings. However, digital bioreactors are growing steadily due to automated operations and data logging features. In terms of technology, benchtop bioreactors are widely used due to low capital requirement and minimal space usage. Academia & research is the key end user segment currently due to ongoing research in biopharmaceuticals, tissue engineering and stem cell products.

Key Takeaways

The global small scale bioreactors market is expected to witness high growth over the forecast period supported by increasing R&D expenditure in biopharmaceutical industry. The global small scale bioreactors market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030.

North America dominates currently led by presence of major biopharma companies and research hubs in the region. Growing applications of single use technologies and continuous manufacturing are providing opportunities for regional growth. European market is gaining traction due to strong government funding for research and development. Rising stem cell and gene therapy research also contributes to regional demand.

Key players operating in the small scale bioreactors market are Merck KGaA ,Danaher Corporation, Getinge AB, Sartorius AG ,Thermo Fisher Scientific Inc. , Lonza Group , Eppendorf AG , Miltenyi Biotec. These players are focusing on capacity expansion across Asia Pacific and Latin America to tap the growth potential offered by emerging biopharma markets in the regions. For instance, In 2021, Thermo Fisher Scientific inaugurated a bioproduction facility in China to support growing biomanufacturing sector.